Quantcast

Latest Mapatumumab Stories

2009-02-04 07:00:00

-Preliminary Data Show Seven of 17 Evaluable Patients Achieved an Objective Tumor Response by End of Four Treatment Cycles- TUSTIN, Calif., Feb. 4 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc.

2009-01-12 06:23:00

- Albuferon(R) for hepatitis C, LymphoStat-B(R) for lupus and ABthrax(R) for inhalation anthrax all progressing rapidly toward commercialization - - GSK Phase 3 trial of darapladib underway in chronic coronary heart disease - - HGS provides 2009 financial guidance; expects less than $25 million net cash burn - ROCKVILLE, Md., Jan.

2008-12-09 09:00:00

SOUTH SAN FRANCISCO, Calif., Dec. 9 /PRNewswire/ -- Proteolix, Inc. today announced positive clinical data demonstrating that the company's lead product, carfilzomib, has single-agent activity and promotes durable responses in patients with relapsed and refractory multiple myeloma.

2008-11-13 03:00:16

ImClone Systems, a developer of novel antibodies to treat cancer, has initiated patient enrollment for its disease-directed Phase II clinical trial of IMC-1121B in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer.

2008-10-30 18:00:29

Cytokinetics, Incorporated (NASDAQ: CYTK), reported revenues from research and development collaborations of $3.1 million for the third quarter of 2008.

2008-10-30 12:01:04

Infinity Pharmaceuticals, a cancer drug discovery and development company, has announced that it has met pre-specified criteria to expand both arms of its ongoing Phase II clinical trial evaluating IPI-504, its lead heat shock protein 90 inhibitor, in patients with advanced non-small cell lung cancer.

2008-10-30 03:00:13

OXiGENE, a biopharmaceutical company, has reported positive interim results from an ongoing Phase II study of Zybrestat in patients with platinum-resistant ovarian cancer.

2008-10-28 09:00:39

Onconova Therapeutics, Inc. announced today the publication of positive results from a first-in-human Phase I clinical trial of its lead anticancer drug, ON 01910.Na, in advanced refractory solid tumors.

2008-10-26 09:00:07

Proteolix has reported positive data from a Phase I clinical trial of carfilzomib in patients with advanced solid tumors.


Word of the Day
edulcoration
  • The act of sweetening by admixture of some saccharine substance.
The word 'edulcoration' comes from a Latin word meaning 'making sweet'.